Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 3.82 -4.02% -0.16
MRNS closed down 4.02 percent on Thursday, April 18, 2019, on 64 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MRNS trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish -4.02%
Down 3 Days in a Row Weakness -4.02%
Down 4 Days in a Row Weakness -4.02%
Down 5 Days in a Row Weakness -4.02%

Older signals for MRNS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Chemistry Physical Sciences Drugs Alcohols Ketones Pregnanes Sedatives Neurosteroids
Is MRNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.54
52 Week Low 2.36
Average Volume 759,107
200-Day Moving Average 5.1925
50-Day Moving Average 3.916
20-Day Moving Average 4.17
10-Day Moving Average 4.275
Average True Range 0.2701
ADX 32.24
+DI 22.3724
-DI 21.124
Chandelier Exit (Long, 3 ATRs ) 3.8797
Chandelier Exit (Short, 3 ATRs ) 4.4503
Upper Bollinger Band 4.6745
Lower Bollinger Band 3.6655
Percent B (%b) 0.15
BandWidth 24.196643
MACD Line 0.0518
MACD Signal Line 0.122
MACD Histogram -0.0702
Fundamentals Value
Market Cap 99.61 Million
Num Shares 26.1 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.47
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.15
Resistance 3 (R3) 4.17 4.08 4.10
Resistance 2 (R2) 4.08 4.00 4.07 4.08
Resistance 1 (R1) 3.95 3.94 3.91 3.93 4.06
Pivot Point 3.86 3.86 3.84 3.85 3.86
Support 1 (S1) 3.73 3.78 3.69 3.71 3.58
Support 2 (S2) 3.64 3.72 3.63 3.56
Support 3 (S3) 3.51 3.64 3.55
Support 4 (S4) 3.49